[MO/URSA-QUALITY] URSA-QUALITY-ADD2: ADD-E Continuation and Maintenance Phase (ADD2)

Object Description

The percentage of members 6–12 years of age with a prescription dispensed for ADHD medication, who remained on the medication for at least 210 days and who, in addition to the visit in the initiation phase, had at least two follow-up visits with a practitioner within 270 days (9 months) after the initiation phase ended. Unadjusted Certified Measure cc1ed12d-1939-42c2-a09c-4bfbb292610b

Metadata

• Table Name: ursa.mo_ursa_quality_add2
• Layer: MEASURE_OBJECT
• Object Type: Measure Object
• Temporal Class: Event
• Case ID: Index Patient ID, Output NCQA Payer Type Code, Snapshot Date
• Event Date: Snapshot Date
• Primary Key: Ursa Serial ID

Published Fields

• Measure Fields

  • Denominator
  • Numerator

• [No Field Group]

  • Ursa Serial ID